جست‌وجوی استاد و پژوهشگر

Joanna Wilsonمشاهده پروفایل

استاد

• Aquatic Toxicology
• Environmental Toxicology
• Cytochrome P450 Enzymes
• +۳ مورد دیگر

Joanna Wilson is a Professor of Biology at McMaster University, specializing in Aquatic Toxicology. Her research focuses on temperature and contaminant stressors in aquatic species, particularly the role of Cytochrome P450 enzymes in contaminant metabolism. She also investigates the effects of pharmaceuticals, metals, and thermal regimes on aquatic organisms, emphasizing developmental and reproductive endpoints critical for population health. Education: Ph.D. Biological Oceanography, Woods Hole Oceanographic Institution (2003) M.Sc. Biology, University of Victoria (1997) H.B.Sc Biology and Pharmacology, McMaster University (1994) Research Interests: Environmental contaminants and their metabolic pathways Thermal stress and heat shock responses Ecotoxicological impacts on fish development and reproduction Teaching: Environmental Physiology (BIOLOGY 728) Topics in Physiology (BIOLOGY 3ZZ3) Fundamental Concepts of Pharmacology (BIOLOGY 3AA3) Labs/Teams: Wilson Toxicology Lab (Website: wilsontoxlab.ca )

• Alzheimer's Disease
• Neurodegenerative Diseases
• Biomarkers
• +۵ مورد دیگر

Eugene Hone is a Post Doctoral Research Fellow in Neuroscience at the School of Medical and Health Sciences, Edith Cowan University (ECU). He holds a Doctor of Philosophy from The University of Western Australia (2010). His research focuses on neurodegenerative diseases, particularly Alzheimer's Disease (AD), with a focus on biomarker discovery, lipid metabolism, and neuroprotective strategies. He has contributed to studies on the role of sorghum polyphenols, mitochondrial dysfunction modulation, and plasma biomarkers like neurofilament light chain. Key research interests include the development of non-invasive diagnostic methods (e.g., hyperspectral retinal imaging), lipid-related pathways in AD, and the therapeutic potential of nutraceuticals. He has led projects funded by organizations such as the National Foundation for Medical Research and Innovation and the Australian Alzheimer's Research Foundation, totaling over $3 million in grants. Current projects explore biomarkers for AD, Parkinson's, and childhood dementia. Dr. Hone has supervised multiple PhD students, including research on sorghum's effects on AD pathology and neurofilament biomarkers. His work bridges clinical research and translational science, aiming to identify early-stage diagnostics and novel treatments for neurodegenerative disorders.

Mark T. W. Ebbertمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Neurodegenerative Disorders
• Genetics
• +۵ مورد دیگر

Mark T. W. Ebbert, PhD, is an Associate Professor at the University of Kentucky's Sanders-Brown Center on Aging, where he leads the Ebbert Lab. His work focuses on developing biomarkers for neurodegenerative diseases, particularly Alzheimer's disease (AD), leveraging cutting-edge genomic and transcriptomic techniques. He co-leads efforts in the Alzheimer's Disease Research Center's Biomarker Core, aiming to integrate neuroimaging, fluid biomarkers, and genomic data for precision medicine applications. Key research interests include analyzing genetic variants, long-read sequencing for disease resilience, and understanding inflammation's role in neurodegeneration. He has presented at high-profile venues like the Markesbery Symposium, discussing topics such as using long-read sequencing to identify AD biomarkers. His lab has produced over 55 publications, with a focus on resolving genomic 'dark regions' and improving biomarker accuracy through innovative methods like RNApysoforms visualization tools. Collaborating with interdisciplinary teams, Dr. Ebbert explores the interplay between genetics, epigenetics, and environmental factors in neurodegenerative diseases. His work bridges basic science and clinical translation, emphasizing the importance of genomic data integration for advancing AD diagnosis and treatment strategies.

Eileen M. Barryمشاهده پروفایل

استاد

• Vaccine Development
• Enteric Pathogens
• Shigella
• +۵ مورد دیگر

Eileen M. Barry serves as Professor in the Department of Medicine at the University of Maryland School of Medicine, with secondary appointments in Medical and Research Technology and Microbiology and Immunology. She directs education for the Center of Vaccine Development & Global Health, leading research on vaccines against enteric pathogens and biodefense threats. Her academic background includes: B.A. in Biology from University of Delaware (1985) Ph.D. in Microbiology and Immunology from Virginia Commonwealth University Medical College of Virginia (1991) Postdoctoral Fellowship at University of Maryland School of Medicine Center for Vaccine Development (1992-1994) Postdoctoral Fellowship at University of Maryland School of Medicine Center for Vaccine Development (1994-1996) Dr. Barry's research focuses on oral live attenuated vaccines targeting Shigella , enterotoxigenic E. coli (ETEC), and Francisella tularensis . Her work spans pathogen engineering, host-pathogen interactions, and clinical translation, with emphasis on pediatric and military applications. Key methodologies include human enteroid models, BSL3/ABSL3 pathogenesis studies, and immunogenicity assessment. Recent publications reveal a strategic shift toward multivalent platforms and advanced organoid systems for predicting human immune responses. Her scientific recognition includes: University System of Maryland PROMISE Alliance Outstanding Faculty Mentor (2015) Faculty Teacher of the Year Award (2011) Teaching Commendation in Host Defenses (2009/2012) As a dedicated mentor, Dr. Barry has served on Graduate Student Admissions Committees since 2007 and received special recognition for advancing underrepresented STEM students. Her substantial NIH funding portfolio includes: P01AI125181: Pathogenesis of E. Coli and Shigella in Human Enteroid Models (2016-2021) R01AI125841: Serological Assays for Shigella Vaccine Efficacy (2016-2021) R01AI123129: Tularemia Vaccine Protection Correlates (2016-2021) Her laboratory operates BSL2/3 and ABSL2/3 facilities, integrating genetic engineering, organoid models, and genomics to dissect enteric pathogenesis and accelerate vaccine development for global health impact.

Pradeep Sunilaمشاهده پروفایل

دانشیار

• Ovarian Cancer
• Cancer Biology
• Immunology
• +۵ مورد دیگر

Dr. Pradeep Sunila is an Associate Professor in the Department of Obstetrics and Gynecology at the Medical College of Wisconsin. She holds a PhD in Immunology from the University of Calicut, India, and a Master’s in Microbiology from the University of Bharathiar, India. Research Focus: Dr. Sunila’s work centers on ovarian cancer metastasis, immune mechanisms driving tumor progression, and overcoming therapeutic resistance. Her lab investigates the role of immune cells, extracellular vesicles, and metabolic reprogramming in tumor microenvironments. Key projects include targeting SPHK1, CD5L, and FXR1 to combat drug resistance. Grants & Awards: NIH R01: Role of Exosomal SPHK1 in Ovarian Cancer Progression Department of Defense: Translational Adaptations in Macrophage for Ovarian Cancer Progression 2023 Liz Tilberis Early Career Development Award (OCRFA) AACR Marsha Rivkin Scholar-In-Training Award Lab Activities: The Pradeep Lab develops innovative mouse models to study hematogenous metastasis and evaluates therapies targeting epigenomic adaptations. Recent work includes preclinical studies on selinexor/eribulin combinations for uterine leiomyosarcoma and biomarker discovery using extracellular vesicle analysis.

Tarun Kapoorمشاهده پروفایل

استاد

• Cancer Research
• Cell Biology
• Chemical Biology
• +۷ مورد دیگر

Tarun Kapoor, Ph.D., is the Pels Family Professor at The Rockefeller University and Director of the Pels Family Center for Biochemistry and Structural Biology. His research focuses on developing chemical tools to study dynamic cellular processes, particularly mechanisms of cell division and cancer therapy targets. He leads the Selma and Lawrence Ruben Laboratory of Chemistry and Cell Biology, integrating biochemistry, biophysics, and chemical biology. Education: B.S., California Institute of Technology (1993); Ph.D., Harvard University (1998) Positions: Professor since 2008; Director, Pels Family Center (2015–present) Key research interests include ATPase inhibitors, microtubule dynamics, and drug resistance mechanisms. His lab has pioneered tools like DrugTargetSeqR to combat resistance and discovered inhibitors for proteins such as spastin and SARS-CoV-2 helicase. Kapoor’s work challenges textbook models of cell division and informs cancer therapies. Awards: Pew Biomedical Scholar (2002), Distinguished Teaching Award (2011), American Society for Cell Biology Fellow Publications highlight breakthroughs in microtubule structure, enzyme inhibition strategies, and ribosome biogenesis. His lab’s multidisciplinary approach bridges basic science and translational medicine.

André Bueno Gamaمشاهده پروفایل

استادیار

• Plant Pathology
• Disease Epidemiology
• Sugarcane Diseases
• +۲ مورد دیگر

André Bueno Gama is Assistant Professor in the Department of Plant Pathology and Crop Physiology at Louisiana State University's College of Agriculture. He specializes in applied and fundamental research on sugarcane diseases affecting Louisiana's agricultural industry. Education: PhD in Plant Pathology, University of Florida (2021) MSc in Plant Pathology, University of São Paulo (2017) BS in Agronomy, University of São Paulo (2015) Dr. Gama's research focuses on the etiology, epidemiology, and management of economically significant sugarcane diseases including red rot, smut, Sugarcane Yellow Leaf Virus, mosaic virus, and ratoon stunt disease. His program employs interdisciplinary approaches with breeders and entomologists to develop integrated disease management strategies. His recent publications (2008-2023) demonstrate expertise in disease management systems, fungicide efficacy, molecular diagnostics, and decision-support tools for crop protection. Research emphasizes practical applications for sugarcane, citrus, strawberry, and turfgrass production systems. Dr. Gama teaches PLHL 7083 (Epidemiology and Crop Loss Assessment), training graduate students in disease dynamics, prediction models, and management strategies. His extension program monitors disease outbreaks and delivers timely solutions to Louisiana growers.

Christopher R Muellerمشاهده پروفایل

استاد

• Epigenetics and epigenomics
• Transcriptomics
• Genomics
• +۵ مورد دیگر

Christopher R. Mueller is a Full Professor in the Department of Biomedical and Molecular Sciences at the School of Medicine, Faculty of Health Sciences, Queen's University at Kingston. He has been a full professor since June 2006 and maintains his research laboratory at the Cancer Research Laboratories located at 10 Stuart St, Kingston, ON. Dr. Mueller is also affiliated with the Cancer Biology & Genetics division of the Queen's Cancer Research Institute and is a member of the Translational Institute of Medicine (TIME). Dr. Mueller received his BSc Honours in Integrated Science Studies from Carleton University (1980), followed by a PhD in Microbiology and Immunology from McGill University (1986), and completed his Post-Doctoral Fellowship in Molecular Biology at the University of Geneva (1989). His primary research focuses on developing liquid biopsy approaches for cancer detection and monitoring. His laboratory has pioneered DNA methylation-based blood tests for various cancers including breast, lung, prostate, ovarian, and pancreatic cancers. A key aspect of his work involves studying the relationship between the Glucocorticoid Receptor, BRCA1, and the Estrogen Receptor in breast tumorigenesis. His research identified methylation of the Glucocorticoid Receptor promoter as a potential biomarker predicting lack of response to anti-estrogen therapy in estrogen receptor-positive breast cancer patients. Dr. Mueller's recent publications demonstrate a strong focus on translating laboratory discoveries into clinical applications. His work on DNA methylation-based liquid biopsies spans multiple cancer types, with particular emphasis on breast cancer subtypes. The research shows a progression from basic molecular mechanisms to clinical validation studies, highlighting his commitment to translational research that directly impacts patient care. A DNA methylation-based liquid biopsy for triple-negative breast cancer (2021) Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer (2020) Region-specific glucocorticoid receptor promoter methylation studies in breast cancer (2019) Through his research, Dr. Mueller is helping transform oncology practice by developing tools that enable earlier cancer detection, better treatment selection, and more effective monitoring of treatment response. His work bridges basic molecular research with clinical applications, positioning him at the forefront of precision oncology.

Zehra TEKİNمشاهده پروفایل

استادیار

• Pharmaceutical Chemistry
• Antioxidant Research
• Phytochemistry
• +۳ مورد دیگر

Zehra TEKİN is an Assistant Professor at Adiyaman University's Faculty of Pharmacy, Department of Basic Pharmacy Sciences. She holds a Doctorate in Pharmaceutical Sciences from Inonu University (2016) and a BSc/MSc in Chemistry from Inonu University (2008–2014). Her research focuses on synthesis of bioactive compounds, antioxidant mechanisms, and phytochemical analysis. Her work emphasizes drug design, enzyme inhibition (e.g., carbonic anhydrase), and natural product-derived molecules. Recent studies include investigations on pomegranate by-products, hawthorn extracts, and synthetic dipeptide conjugates. She has published six peer-reviewed articles and participated in multiple research projects funded by Adiyaman University. Key projects include phytochemical studies on pomegranate and hawthorn, and synthesis of anticancer/antioxidant pyrazole derivatives. She teaches courses in biochemistry and analytical chemistry at the Faculty of Pharmacy.

Onur Alptürkمشاهده پروفایل

دانشیار

• Polymer Chemistry
• Drug Delivery Systems
• Nanocarrier Design
• +۴ مورد دیگر

Onur Alptürk serves as an Associate Professor ( Docent ) in the Department of Chemistry at Istanbul Technical University, where he leads a research group focused on advanced polymer-based drug delivery systems. His work bridges synthetic polymer chemistry with biomedical applications, particularly in cancer therapeutics and antimicrobial technologies. His primary research interests include poly(2-oxazoline) chemistry , peptide-conjugated nanocarriers , and core-shell hybrid nanoparticles . Current investigations emphasize developing folate receptor-targeted imaging agents, PDL1-inhibiting peptidomimetics for immunotherapy, and antimicrobial peptide hydrogels for wound dressings. His methodology combines controlled polymerization techniques with bioconjugation strategies to create stimuli-responsive delivery systems. Alptürk has secured 9 competitive research grants as Principal Investigator, including projects on PET imaging agents (2020-2021), antimicrobial wound dressings (2024-2025), and cancer-targeted nanocarriers (2019-2022). His supervised works portfolio spans 19 academic contributions, though specific student names aren't publicly listed. His laboratory specializes in polymer characterization techniques including NMR, GPC, DLS, and TEM for nanoparticle analysis.

Clare Andrewsمشاهده پروفایل

مدرس

• Animal Behavior
• Developmental Psychology
• Stress Physiology
• +۴ مورد دیگر

Dr. Clare Andrews is a Lecturer in Psychology at the University of Stirling. Her research focuses on animal behavior, developmental biology, and stress physiology, particularly in European starlings and burying beetles. She investigates how early-life experiences influence adult behavior, physiological stress responses, and aging processes. Her work bridges evolutionary biology, ecology, and psychology, exploring topics such as food insecurity effects, decision-making under environmental pressures, and the biological underpinnings of aging. Her research employs experimental approaches to study stress physiology, metabolic adaptations, and cognitive behaviors in avian species. Key themes include the impact of early adversity on later-life traits, the interplay between biological aging and stress resilience, and the evolutionary implications of parental care strategies. Recent studies have expanded into societal policy analysis regarding animal welfare, such as frameworks for assessing dog laws in the UK. Andrews has published extensively on topics ranging from energy allocation strategies in birds to the insurance hypothesis of human obesity. Her work frequently integrates field observations with controlled laboratory experiments, emphasizing translational insights for both animal welfare and human health contexts. Her collaborative projects with institutions like the University of Newcastle and Edinburgh have explored telomere dynamics, neuroendocrine systems, and behavioral ecology. While no specific grants or awards are listed, her publications demonstrate sustained engagement with high-impact journals in behavioral ecology and animal welfare science.

• Molecular Biology
• Genetic Biology
• Invertebrate Neurobiology
• +۳ مورد دیگر

Dr. Fernando Calahorro Nunez is a Research Fellow at the University of Southampton, specializing in molecular and genetic biology with a focus on cellular circuits and atypical behaviors. He utilizes Caenorhabditis elegans as a model organism to study gene functions in complex behaviors, particularly in the context of drug discovery for neurodevelopmental disorders and parasitic nematode biology. His work bridges fundamental research with applied studies, collaborating with agrochemical industries to develop novel antiparasitic compounds. His research interests span molecular neurobiology, invertebrate behavior, and drug discovery, with notable contributions to understanding neuroligin-dependent social behaviors and cholinergic signaling pathways. Current projects include investigating autism-associated genes and developing microfluidic assays for drug screening in neurobehavioral disorders. Dr. Calahorro’s expertise in parasitic nematode neurobiology has positioned him to explore host plant invasion mechanisms and test compound libraries for antiparasitic effects. His interdisciplinary approach integrates genetic, pharmacological, and behavioral analyses to address both basic and translational research questions.

• Biomedical Engineering
• Mechanical Engineering
• Nanotechnology
• +۷ مورد دیگر

Dr. Francisco Tovar Lopez is a Lecturer at the School of Engineering, RMIT University. He holds a B.Eng in Mechanical Engineering from UNAM and a PhD in Biomedical Engineering from RMIT. His research focuses on advancing biomedical technologies through microfluidics, nanotechnology, and computational modeling. He has pioneered projects in artificial organs, blood clot detection systems, and lab-on-a-chip platforms. Dr. Tovar has secured notable awards including the ARC-DECRA fellowship and Mexico’s SNI-I recognition. His work bridges mechanical engineering with healthcare applications, emphasizing fluid dynamics and biomaterials. Education B.Eng in Mechanical Engineering (UNAM) PhD in Biomedical Engineering (RMIT University) Research Interests Lab-on-a-Chip technologies Micro/nanofabrication Blood flow dynamics and thrombosis Portable diagnostic systems Medical sensor development Recent Article Trends His 2023 work emphasizes ECMO oxygenator thrombosis detection and environmental sensor applications, reflecting growing focus on translational biomedical engineering. Key themes include microfluidic platforms for hematology and integration of nanoscale sensors. Awards DECRA-ARC Fellow (2012) VC Research Fellow (2012) National Research System Level 1 (Mexico, 2014) Advising Open to PhD supervision in areas like real-time medicine and lab-on-a-chip cancer detection. Active in industry collaborations through projects like Vitalmex Innovamedica.

Catherine M. Klapperichمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Device Development
• Global Health
• +۴ مورد دیگر

Catherine M. Klapperich is a Professor of Biomedical Engineering at Boston University, with joint appointments in Materials Science & Engineering and Mechanical Engineering. She directs the Klapperich Laboratory, focusing on developing diagnostic technologies for women’s health and low-resource settings. Her work includes microfluidic devices, point-of-care diagnostics for sexually transmitted infections (STIs), and hormone monitoring systems. Klapperich holds leadership roles as Director of the Precision Diagnostic Center and the Center for Future Technologies in Cancer Care, and she co-founded the Engineering for Women’s Health (Eng4WH) conference. She has received multiple accolades, including AAAS Fellowship and BU’s Societal Engineer Award. Education: PhD in Mechanical Engineering (UC Berkeley), S.M. in Engineering Sciences (Harvard), B.S. in Materials Science (Northwestern). Prior roles include postdoctoral research at Lawrence Berkeley Lab and industry experience at Aclara Biosciences. Her research integrates biomaterials, nanotechnology, and systems engineering to address global healthcare challenges, emphasizing accessibility and affordability. Awards: AAAS Fellow (2020), BU Teaching Excellence Award (2021), BMES Fellow (2018) Labs/Initiatives: Klapperich Lab, Precision Diagnostic Center, Eng4WH Grants/Funding: Kern Family Foundation Fellowships, Dorf-Ebner Faculty Fellowships Her publications emphasize molecular diagnostics, biosensor innovation, and pandemic response strategies, with recent work on SARS-CoV-2 transmission dynamics and novel CRISPR-based assays. Klapperich’s interdisciplinary approach bridges engineering, medicine, and public health to create impactful solutions for global healthcare equity.

Rasha Rezkمشاهده پروفایل

عضو هیئت علمی

• Microfluidic Technologies
• Biomechanics
• Drug Delivery Systems
• +۵ مورد دیگر

Dr. Rasha Rezk is an Associate Lecturer in the Department of Biology at the University of York and a Royal Academy of Engineering Enterprise Fellow. Her research focuses on microfluidic technologies for biomedical applications, including mechanoporation systems for drug delivery and genome editing. She leads projects on blood stem cell biomechanics, cancer therapy innovations, and advanced therapeutics development. Rasha holds a PhD from the University of Cambridge and has been recognized as a 2024 graduate of the Creation Destruction Lab (Advanced Therapies). Her educational background includes a prestigious Independent Research Fellowship at Cambridge, complementing her academic career. Research interests emphasize leveraging mechanical forces to manipulate cellular behavior, with applications in leukemia treatment and non-viral genome editing. The ForCell platform, developed under her guidance, represents a breakthrough in mechanoporation for therapeutic delivery. Key projects include investigating biomechanical links to gene expression in blood cells and developing tuneable mechanical platforms for safe cargo delivery. Awards include the Royal Academy of Engineering Enterprise Fellowship and CDS Lab accreditation. Rasha actively supervises MSc projects in biomedical science and collaborates on grants for microfluidic technology advancements. Her work spans diverse fields from materials science to oncology, with a focus on translating lab innovations into clinical applications. Current efforts include refining the ForCell system for broader biomedical use and exploring plant synthetic biology applications of microfluidics.